Good At

He specializes in minimally invasive surgery, interventional ablation and cell therapy of thoracic tumors, thoracoscopic lobectomy and lung segment resection, radical esophageal cancer resection, mediastinal tumor resection, pulmonary nodule ablation treatment, and tumor cell immunotherapy.

Introduction

Doctor of Medicine, Deputy Chief Physician, Postdoctoral Doctor of Tumor Immunology, Master Supervisor. Clinical work: Minimally invasive surgery and standardized treatment of thoracic diseases, differentiation and risk assessment of benign and malignant pulmonary nodules, infiltration risk of pulmonary ground-glass nodules and selection of surgical timing, tumor immune cell treatment. Scientific research direction: tumor immunity and cell therapy. Hosted a general project of Shanghai City Natural Science Foundation; presided over a scientific research project of China Postdoctoral Science Foundation "Basic Research on Epha2-FAP-Car-T Cells Combined with IL-15 in the Treatment of Esophageal Cancer"; presided over a general clinical research project of Shanghai City Health Commission "Application of Cytokine-Carrying Mesenchymal Stem Cells in Immunotherapy of Non-Small Cell Lung Cancer"; Hosted the international clinical registration studies "Clinical Study on Autologous Tumor-Invasive Lymphocytes (TILs) in the Treatment of Relapsed and Refractory Non-Small Cell Lung Cancer" and "Clinical Study on Autologous Immune Cells in the Treatment of Ground Glass Nodules (GGN)"; completed the department-level scientific research project "Clinical Study on Meso Car-T Cells Expressing PD-1 Antibodies in the Treatment of Recurrent Non-Small Cell Lung Cancer After Post-Operation Chemotherapy." Published more than 10 SCI papers. The research results were published in Advanced Science (impact factor IF=16.806),IJO,JCB,JTD and other journals.